Early potassium channel blockade improves sepsis‐induced organ damage and cardiovascular dysfunction
Open Access
- 15 March 2011
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 163 (6), 1289-1301
- https://doi.org/10.1111/j.1476-5381.2011.01324.x
Abstract
BACKGROUND AND PURPOSE There is increasing evidence that potassium channels are involved in the cardiovascular dysfunction of sepsis. This evidence was obtained after the systemic inflammation, cardiovascular dysfunction and organ damage had developed. Here we have studied the consequences of early interference with potassium channels on development of sepsis. EXPERIMENTAL APPROACH Sepsis was induced by caecal ligation and puncture (CLP) or sham surgery in Wistar rats. Four hours after surgery, animals received tetraethylammonium (TEA; a non-selective potassium channel blocker) or glibenclamide (a selective ATP-sensitive potassium channel blocker). Twenty-four hours after surgery, inflammatory, biochemical, haemodynamic parameters and survival were evaluated. KEY RESULTS Sepsis significantly increased plasma NOx levels, expression of inducible nitric oxide synthase (NOS-2) protein in lung and thigh skeletal muscle, lung myeloperoxidase, urea, creatinine and lactate levels, TNF-α and IL-1β, hypotension and hyporesponsiveness to phenylephrine and hyperglycemia followed by hypoglycemia. TEA injected 4 h after surgery attenuated the increased NOS-2 expression, reduced plasma NOx, lung myeloperoxidase activity, levels of TNF-α and IL-1β, urea, creatinine and lactate levels, prevented development of hypotension and hyporesponsiveness to phenylephrine, the alterations in plasma glucose and reduced late mortality by 50%. Glibenclamide did not improve any of the measured parameters and increased mortality rate, probably due to worsening the hypoglycemic phase of sepsis. CONCLUSIONS AND IMPLICATIONS Early blockade of TEA-sensitive (but not the ATP-sensitive subtype) potassium channels reduced organ damage and mortality in experimental sepsis. This beneficial effect seems to be, at least in part, due to reduction in NOS-2 expression.Keywords
This publication has 54 references indexed in Scilit:
- Differential Involvement of Potassium Channel Subtypes in Early and Late Sepsis-induced Hyporesponsiveness to VasoconstrictorsJournal of Cardiovascular Pharmacology, 2010
- Guide to Receptors and Channels (GRAC), 4th editionBritish Journal of Pharmacology, 2009
- GLIBENCLAMIDE DOSE RESPONSE IN PATIENTS WITH SEPTIC SHOCKShock, 2007
- SHORT-TERM EFFECTS OF GLIPIZIDE (AN ADENOSINE TRIPHOSPHATE-SENSITIVE POTASSIUM CHANNEL INHIBITOR) ON CARDIOPULMONARY HEMODYNAMICS AND GLOBAL OXYGEN TRANSPORT IN HEALTHY AND ENDOTOXEMIC SHEEPShock, 2006
- Potassium channels and septic shock*Critical Care Medicine, 2006
- Effect of Potassium Channel and Cytochrome P450 Inhibition on Transient Hypotension and Survival during Lipopolysaccharide-Induced Endotoxic Shock in the RatPharmacology, 2005
- The pore-forming subunit of the KATP channel is an important molecular target for LPS-induced vascular hyporeactivity in vitroBritish Journal of Pharmacology, 2005
- Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock*Critical Care Medicine, 2004
- A K+ channel is involved in LPS signalingInnate Immunity, 2001
- Abnormal Activation of K+Channels Underlies Relaxation to Bacterial Lipopolysaccharide in Rat AortaBiochemical and Biophysical Research Communications, 1996